Compare ELVN & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
Current Price
| Metric | ELVN | IRS |
|---|---|---|
| Founded | 2016 | 1943 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.4B |
| IPO Year | 2020 | 1994 |
| Metric | ELVN | IRS |
|---|---|---|
| Price | $26.91 | $15.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $41.00 | N/A |
| AVG Volume (30 Days) | ★ 846.8K | 199.7K |
| Earning Date | 03-12-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 9.17% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | N/A | ★ $336,336,669.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.66 |
| Revenue Growth | N/A | ★ 2.09 |
| 52 Week Low | $13.30 | $10.61 |
| 52 Week High | $30.22 | $19.14 |
| Indicator | ELVN | IRS |
|---|---|---|
| Relative Strength Index (RSI) | 59.50 | 34.77 |
| Support Level | $26.43 | $14.95 |
| Resistance Level | $28.60 | $16.29 |
| Average True Range (ATR) | 1.51 | 0.95 |
| MACD | -0.24 | -0.28 |
| Stochastic Oscillator | 53.24 | 1.62 |
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segments include Shopping Malls, which comprise lease and service revenues principally related to the rental of commercial and other spaces in the company's shopping malls; Offices, which include lease revenues and other service revenues related to office activities; Sales and Developments, which include the development, maintenance, and sales of undeveloped parcels of land and/or trading properties; Hotels, which mainly include revenues from rooms, catering, and restaurants; and others. The company generates the majority of its revenue from the Shopping Malls segment.